Bone Grafts and Substitutes Market to Exceed USD 4.4 billion by 2028, Expanding at a 4.9% CAGR: TMR Report
September 29, 2023 02:26 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The bone grafts and substitutes market was estimated to have acquired US$ 3 billion in...
Xtant™ Medical to Present at the Canaccord Genuity 2016 Musculoskeletal Conference
February 16, 2016 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading...
Xtant™ Medical To Present at ICV Manhattan Conference
December 03, 2015 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), formerly Bacterin International Holdings, Inc., a leader in the development of class-leading regenerative...
Xtant Medical Holdings, Inc. Reports Third Quarter 2015 Results
November 11, 2015 16:27 ET
|
Xtant Medical Holdings, Inc.
Third Quarter 2015 Consolidated Pro Forma Highlights: Consolidated pro forma revenue increased 6.5% to $20.9 million from $19.6 million in the third quarter of 2014. Excluding OEM revenue,...
Xtant Medical Announces First Surgical Use of OsteoSelect® PLUS DBM Putty
November 03, 2015 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...
Xtant(TM) Medical Exhibits at North American Spine Society (NASS) Meeting
October 12, 2015 13:13 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced...
Xtant(TM) Medical Awarded Grant From the Montana Board of Research and Commercialization Technology
October 06, 2015 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 06, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced...